Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04473378 · ClinicalTrials.gov registry record
Glucose Monitoring During Chemotherapy
A clinical trial, sponsored by Columbia University.
- Completed
- Registry status
- 22
- Enrollment target
NCT04473378 is a clinical trial that has completed, run by Columbia University. The registered enrollment target is 22 participants.
The verdict
NCT04473378 has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
Study Summary
This is a research study to look at blood sugar changes during chemotherapy using a continuous blood sugar monitoring device. The device uses patches that attach to the skin on the back of the arm to measure blood sugar changes for the duration of the chemotherapy course. Each patch lasts for about 2-weeks. During chemotherapy visits, new patches will be placed and will be worn until the chemotherapy course is complete. Participants will be in this study for 6 months. Approximately 50 patients will be enrolled in this study.
Interventions
- DEVICE FreeStyle Libre Pro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2019-10-31 |
| Est. Completion | 2022-08-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04473378
The ClinicalTrials.gov registry entry for NCT04473378 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FreeStyle Libre Pro is the first listed.
NCT04473378 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04473378 about?
NCT04473378 is a clinical study titled "Glucose Monitoring During Chemotherapy". This is a research study to look at blood sugar changes during chemotherapy using a continuous blood sugar monitoring device. The device uses patches that attach to the skin on the back of the arm to measure blood sugar changes for the duration of the chemotherapy course. Each patch lasts for about ...
What is the current status of trial NCT04473378?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2019-10-31. Estimated completion is 2022-08-17.
What interventions are being tested in trial NCT04473378?
The interventions under investigation include: FreeStyle Libre Pro (DEVICE).
Who is sponsoring clinical trial NCT04473378?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.